Latest News

medimmune_astrazeneca_cancer_pd-l1_nsclc_trial_pd_l1

Immuno-Oncology Combo works on Lung Cancer Regardless of PD-L1 Type

AstraZeneca’s MedImmune (UK) has published phase Ib study results in The Lancet Oncology. These showed anti-tumour activity of a combination of investigational antibodies in patients with lung cancer. The trial considered patients undergoing treatment with durvalumab and tremelimumab, to see whether the drug combo …

READ MORE →
internet_investors_biotech_code

When the Biggest Tech Investors Go Wild for Biotech

Biotech is catching new investors’ interest. Just in 2015, Google Ventures, the accelerator Y Combinator, Andreessen Horowitz (one of the most successful early-stage investment funds in the Valley) and Peter Thiel (founder of Paypal) showed their interest in Biotech. Why? And why …

READ MORE →
deinove_carotenoids_synbio_greentech_deinochem

Synthetic Biology Breakthrough in Production of Natural Carotenoids

The SynBio Biotech, Deinove (France), is hoping to break into the Carotenoid market for food, cosmetics and animal feed. Now, with their Deinococcus platform they have made several major advancements in their endeavours. Deinove also partnered with the Canadian company POS Bio-Sciences last year to try and kickstart the …

READ MORE →
carat_car_t_cell_eu_commission_fund

The European Union Finances the Future of CAR-T Manufacturing

CAR-T is the way forward in Cancer therapeutics, which is one of the leading causes of Mortality in the Western world. Now this European consortium has amassed €6M for a more unified approach to CAR-T under a European Union Commission …

READ MORE →
epic_science_gene_editing_nanoinjection_bioprinting

Epic Science Footage: Atomic Animation to 3D BioPrinting Organs Caught on Camera

Here is some Epic Footage in Science and Technology from Research centres across the world.. Put together by Hashem AL-ghaili, this “Epic Science” compilation of videos  (around 5 minutes worth) comes from many key research institutions, including the Karolinska Institutet in Sweden …

READ MORE →
tedopi_nsclc_lung_cancer_ose_pharma_atlante

French Biotech Launches Phase III Global Trial for Lung Cancer Drug

OSE Pharma (France) has initiated the US phase III trial, Atalante 1. This global, pivotal trial will evaluate Tedopi, the company’s lead product, for advanced non-small cell lung cancer (NSCLC). The phase III study was initiated in Europe in early 2016, so …

READ MORE →
forbes_under_30_biotech_eu_innovators

Here are 8 of Forbes’ Under 30 Year Olds Transforming European Biotech

Here are 8 of the top European innovators under 30 which are part of the Biotech Ecosystem… After reading Forbes ’30 Under 30′ ranking in the Science and Healthcare field in Europe, we decided to list a few of these impressive individuals …

READ MORE →
week_biotech_crispr

What happened this week? CRISPR, Microbiome, Algae in Biotech

Monday: Huge Milestone: UK Approves CRISPR Editing on Human Embryos Tuesday: Ultimate Review: The Unlimited Biotech Potential of Algae Wednesday: Meet the CEO of Europe’s Leading Microbiome Biotech Thursday: Zika Virus: Who in Biotech is Working to Stop its Spread? …

READ MORE →
bioart_jalila_ESSAiDI_heart_bulletproof_spider_skin_silk_eindhoven

BioArt: Engineering Bulletproof Skin and Organ Transplant Scaffolds with Goat Milk Spider Silk

Jalila Essaïdi is creating BioArt in Eindhoven (Netherlands), through strong biotechnological applications of Spider Silk. She even directs her own company, Inspidere, which makes the stuff from Goat’s milk. Bulletproof Skin (2011) is also known as 2.6g 329m/s (the performance standard for bulletproof vests). …

READ MORE →
banner_effimune

Biotech of the week: Effimune, the French Success-story in autoimmune disease

This week, we leave central Spain and head North-East, across the Pyrenees and head to the largest city in ‘Traditional Brittany’, France, and also the this week’s location, Nantes. This picturesque city was voted the most Green in EU (2013), …

READ MORE →
riboxx_life_sciences_rna_cancer_tollys_biotech

German RNA Specialist Could Break French Biotech into the Cancer Ecosystem

Riboxx Life Sciences (Germany) has licensed out its drug development platform APOXXIM to a small biotech, Tollys SAS in Lyon (France) to investigate a specific type of Cancer therapy. Riboxx develops customized and tailor-made molecular tools for gene silencing in vitro and …

READ MORE →
Moustique tigre

Zika Virus: Who in Biotech is Working to Stop its Spread?

The Zika virus epidemic could infect up to 4 Million people. As a cousin to Dengue Fever, what are the risks? Who in the Biotech and pharma world are working on a vaccine? And what is exactly this virus which …

READ MORE →

Inside Labiotech

Philip_Joachim_Jan16_Labiotech

How we Raised our First Seed Round to Build the Next TechCrunch for Biotech

You may have read it on Tech.eu (the biggest EU Startup blog), Gründerszene (the biggest German startup magazine) or in Maddyness (the biggest French Startup magazine) yesterday: Yes, we raised our first seed fundraising to become ‘the next TechCrunch’ for Biotech! The …

READ MORE →
outside

Become a Sponsor of EU’s Most Refreshing Biotech Conference

As you might now know after our last month’s announcement, we are shaping a new kind of biotech event with the launch of Labiotech Refresh, Europe’s most refreshing Biotech conference. With this one-day conference happening in Berlin on May 24th, …

READ MORE →

Event Planning

Don't Miss The Hottest European Biotech News!